Perceptive Advisors LLC United Therapeutics Corp Transaction History

Perceptive Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $15.6 Million - $20.1 Million	-94,064 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $8.78 Million - $10.3 Million	-47,636 Reduced 33.62%	94,064 $20.3 Million
Q3 2021 Nov 15, 2021	SELL	$179.86 - $214.88 $85.5 Million - $102 Million	-475,102 Reduced 77.03%	141,700 $26.2 Million
Q2 2021 Aug 16, 2021	BUY	$170.47 - $211.93 $75.3 Million - $93.6 Million	441,802 Added 252.46%	616,802 $111 Million
Q1 2021 May 17, 2021	BUY	$153.94 - $174.85 $26.9 Million - $30.6 Million	175,000 New	175,000 $29.3 Million

673

42.2M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.